CP-158 Our experience with fampridine in patients with multiple sclerosis after 2 years of treatment

A Escolano Pueyo; H Navarro; C Perez; B Sebastian; M Seral; M Abad

doi:10.1136/ejhpharm-2015-000639.151

Article info

PDF

Clinical pharmacy

CP-158 Our experience with fampridine in patients with multiple sclerosis after 2 years of treatment

Authors

A Escolano Pueyo 1Universitary Hospital Miguel Servet, Pharmacy, Zaragoza, Spain PubMed articles Google scholar articles
H Navarro 1Universitary Hospital Miguel Servet, Pharmacy, Zaragoza, Spain PubMed articles Google scholar articles
C Perez 1Universitary Hospital Miguel Servet, Pharmacy, Zaragoza, Spain PubMed articles Google scholar articles
B Sebastian 2Universitary Hospital Miguel Servet, Neurology Service, Zaragoza, Spain PubMed articles Google scholar articles
M Seral 2Universitary Hospital Miguel Servet, Neurology Service, Zaragoza, Spain PubMed articles Google scholar articles
M Abad 1Universitary Hospital Miguel Servet, Pharmacy, Zaragoza, Spain PubMed articles Google scholar articles

Citation

Escolano Pueyo A, Navarro H, Perez C, et al

CP-158 Our experience with fampridine in patients with multiple sclerosis after 2 years of treatment

European Journal of Hospital Pharmacy 2015;22:A63-A64.

Publication history

First published March 24, 2015.

Online issue publication

May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password